A space for sharing and discussing news related to global current events, technology, and society.
69551 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
A space for sharing and discussing news related to global current events, technology, and society.
69551 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
Relevant
Hot
New
Spam
Relevant
Hot
New
Spam
0
24.3K
0
24.3K
"The case will hinge on the question of whether Pfizer put the same microchips in their vaccines as Moderna or if they used unique mind control programming."
"The case will hinge on the question of whether Pfizer put the same microchips in their vaccines as Moderna or if they used unique mind control programming."
0
141
0
141
>"Moderna on Friday filed patent infringement lawsuits against Pfizer and BioNTech "for infringing patents central to (its) mRNA technology platform," _...Read More_
>"Moderna on Friday filed patent infringement lawsuits against Pfizer and BioNTech "for infringing patents central to (its) mRNA technology platform," _...Read More_
0
400
0
400
"The Food and Drug Administration plans to authorize updated versions of Pfizer-BioNTech’s and Moderna’s Covid boosters around Labor Day, said two people familiar with the discussions."
"The Food and Drug Administration plans to authorize updated versions of Pfizer-BioNTech’s and Moderna’s Covid boosters around Labor Day, said two people familiar with the discussions."
0
3.3K
0
3.3K
The New York Times: F.D.A. Says Next Covid Boosters Should Target Omicron Subvariants. >"The decision was an acknowledgment that the current shots may no longer be _...Read More_
The New York Times: F.D.A. Says Next Covid Boosters Should Target Omicron Subvariants. >"The decision was an acknowledgment that the current shots may no longer be _...Read More_
0
199
0
199
"In deliberations over whether to recommend Covid vaccines for young children, scientific advisers to the Centers for Disease Control and Evaluation on Friday wrestled with the complexities of evaluating two very different vaccines, and _...Read More_
"In deliberations over whether to recommend Covid vaccines for young children, scientific advisers to the Centers for Disease Control and Evaluation on Friday wrestled with the complexities of evaluating two very different vaccines, and _...Read More_
0
217
0
217
The New York Times: F.D.A. Panel Recommends Pfizer and Moderna Vaccines for Youngest Children. >"States have already ordered millions of doses; if the agency _...Read More_
The New York Times: F.D.A. Panel Recommends Pfizer and Moderna Vaccines for Youngest Children. >"States have already ordered millions of doses; if the agency _...Read More_
0
592
0
592
"Scientific advisers to the Centers for Disease Control and Prevention on Thursday recommended a booster dose of the Pfizer-BioNTech vaccine for children ages 5 to 11."
"Scientific advisers to the Centers for Disease Control and Prevention on Thursday recommended a booster dose of the Pfizer-BioNTech vaccine for children ages 5 to 11."
0
28.3K
0
28.3K
>"A third dose would enhance immunity to the coronavirus, the agency said. But hesitancy is high, and less than one-third of children in this age group have _...Read More_
>"A third dose would enhance immunity to the coronavirus, the agency said. But hesitancy is high, and less than one-third of children in this age group have _...Read More_
0
30.5K
0
30.5K
"The Food and Drug Administration is expected to authorize booster shots of the Pfizer-BioNTech coronavirus vaccine for children ages 5 to 11 as soon as Tuesday, making an extra dose available to protect school-age children as a descendant _...Read More_
"The Food and Drug Administration is expected to authorize booster shots of the Pfizer-BioNTech coronavirus vaccine for children ages 5 to 11 as soon as Tuesday, making an extra dose available to protect school-age children as a descendant _...Read More_
0
175
0
175
The New York Times: F.D.A. Sets Aside June for Potential Decisions on Vaccines for Children Under 5. >"Both Moderna and Pfizer-BioNTech have asked the agency _...Read More_
The New York Times: F.D.A. Sets Aside June for Potential Decisions on Vaccines for Children Under 5. >"Both Moderna and Pfizer-BioNTech have asked the agency _...Read More_
0
5.4K
0
5.4K
" The Biden administration is planning to give Americans age 50 or older the option of a second booster of the Pfizer-BioNTech or Moderna coronavirus vaccine without recommending outright that they get one, according to several people _...Read More_
" The Biden administration is planning to give Americans age 50 or older the option of a second booster of the Pfizer-BioNTech or Moderna coronavirus vaccine without recommending outright that they get one, according to several people _...Read More_
0
32.6K
0
32.6K
"Pharmaceutical giant Pfizer and its partner, BioNTech, will seek emergency authorization for a second booster shot of their coronavirus vaccine for people 65 and older, an effort to bolster waning immunity that occurs several months after _...Read More_
"Pharmaceutical giant Pfizer and its partner, BioNTech, will seek emergency authorization for a second booster shot of their coronavirus vaccine for people 65 and older, an effort to bolster waning immunity that occurs several months after _...Read More_
0
110
0
110
"Shares of the major vaccine makers rose on Monday as China battles its worst Covid outbreak since 2020, fueling fear that the pandemic will drag on which could drive demand for future vaccine orders."
"Shares of the major vaccine makers rose on Monday as China battles its worst Covid outbreak since 2020, fueling fear that the pandemic will drag on which could drive demand for future vaccine orders."
0
189
0
189
"The Pfizer-BioNTech vaccine’s ability to prevent coronavirus infections in children 5 to 11 years old waned over time although the shot continued to protect against the most serious outcomes, including hospitalization and death, even as _...Read More_
"The Pfizer-BioNTech vaccine’s ability to prevent coronavirus infections in children 5 to 11 years old waned over time although the shot continued to protect against the most serious outcomes, including hospitalization and death, even as _...Read More_
0
175
0
175
"The European Medicines Agency’s safety committee said on Friday it was reviewing reports of heavy menstrual bleeding and absence of menstruation from women who had received Covid-19 vaccines from Pfizer/BioNTech and Moderna."
"The European Medicines Agency’s safety committee said on Friday it was reviewing reports of heavy menstrual bleeding and absence of menstruation from women who had received Covid-19 vaccines from Pfizer/BioNTech and Moderna."